SCHEMBL1780245

SCHEMBL1780245

Clc1ccc2c(Cl)cccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.58
CYP2A6 P11509 3/20 0.58
TP53 P04637 2/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
C1R P00736 1/20 0.38
NR4A2 P43354 2/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
AHR P35869 1/20 0.38
HTT P42858 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30366437 1.00 CYP1A2 (0.58) CYP1A2CYP2A6TP53HSD17B1HSD17B2
SCHEMBL30366566 1.00 CYP1A2 (0.58) CYP1A2CYP2A6TP53HSD17B1HSD17B2
SCHEMBL8208536 0.83 CYP2A6 (0.68) CYP1A2CYP2A6MEN1ALDH1A1KMT2A
SCHEMBL145859 0.83 CYP2A6 (0.68) CYP1A2CYP2A6MEN1ALDH1A1KMT2A
SCHEMBL6561452 0.81 CYP2A6 (0.58) CYP1A2CYP2A6TP53CYP3A4ALDH1A1
SCHEMBL30366567 0.81 CYP2A6 (0.58) CYP1A2CYP2A6TP53CYP3A4ALDH1A1
SCHEMBL29972350 0.79 CYP2A6 (0.62) CYP1A2CYP2A6HSD17B1HSD17B2CYP3A4
SCHEMBL5668937 0.79 CYP2A6 (0.62) CYP1A2CYP2A6HSD17B1HSD17B2CYP3A4
Chlorobenzene SCHEMBL28112104 0.78 CYP1A2 (0.61) CYP1A2CYP2A6ALDH1A1TSHRTDP1
Methyl Alcohol SCHEMBL28240100 0.78 CYP2A6 (0.61) CYP1A2CYP2A6MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025094673-A1 VINYL COMPOUND, VINYL COMPOSITION, VINYL RESIN CURED PRODUCT, PREPREG, FILM WITH RESIN, METAL FOIL WITH RESIN, METAL-CLAD LAMINATE, AND PRINTED WIRING BOARD 住友化学株式会社 2025-05-08 WO disclosed
US-11912708-B2 Macrocyclic heterocycles and uses thereof KUMQUAT BIOSCIENCES INC. (US) 2024-02-27 US disclosed
US-20230399302-A1 PROCESS FOR THE PREPARATION OF HETEROARYL-SUBSTITUTED SULFUR(VI) COMPOUNDS NATIONAL INSTITUTES OF HEALTH 2023-12-14 US disclosed
US-20230339952-A1 MACROCYCLIC HETEROCYCLES AND USES THEREOF KUMQUAT BIOSCIENCES INC. 2023-10-26 US disclosed
CN-115991815-A Halogenated modified prepared photoresist resin material and preparation method thereof 中国科学院长春应用化学研究所 2023-04-21 CN disclosed
US-10793584-B2 Naphthobischalcogenadiazole derivative and production method therefor OSAKA UNIVERSITY (JP) 2020-10-06 US disclosed
US-20190337966-A1 NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR OSAKA UNIVERSITY (JP) 2019-11-07 US disclosed
US-20190214583-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-07-11 US disclosed
WO-2018123207-A1 NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR 国立大学法人大阪大学 2018-07-05 WO disclosed
CN-106083606-A A kind of 2,6 diphenyl naphthalene derivativeses and its preparation method and application 长春海谱润斯科技有限公司 2016-11-09 CN disclosed
US-4758639-A Process for production of vinyl polymer SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-19 US disclosed
US-4757124-A Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-12 US disclosed
CN-85107531-A Process for producing vinyl chloride polymer 1987-01-21 CN disclosed
EP-0172427-A2 Process for production of vinyl chloride polymer Shin-Etsu Chemical Co., Ltd. (JP) 1986-02-26 EP disclosed
US-4487713-A HEAT TREATMENT WITH TITANIUM, TIN, ANTIMONY OR ZIRCONIUM COMPOUND EXXON RESEARCH & ENGINEERING CO. (US) 1984-12-11 US disclosed
US-4182915-A PHENOL FROM BENZENE BY REACTION OF THALLIUM/III/ METALLATE WITH HYDROXYL DONOR HALCON INTERNATIONAL, INC. (US) 1980-01-08 US disclosed
US-4166829-A Linear diene polymer having reactive terminal groups and method of preparing the same MEHNERT WOLFGANG (DE) 1979-09-04 US disclosed
US-4031106-A Synthesis of aromatic amines by reaction of aromatic compounds with ammonia E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-06-21 US disclosed
US-4001260-A NICKEL-NICKEL OXIDE-ZIRCONIUM OXIDE AMINATION CATALYST E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-01-04 US disclosed
US-3936473-A COPPER OR NOBLE METAL SALT, OXYGEN AND ORGANIC ACID CATALYST UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10793584-B2 Naphthobischalcogenadiazole derivative and production method therefor CYP24A1, CYP26B1, CYP21A2 CYP1A2 115/4885CYP2A6 96/4885TP53 3878/4885
US-11912708-B2 Macrocyclic heterocycles and uses thereof HRAS, KRAS, TP53 CYP1A2 4819/4885CYP2A6 4850/4885TP53 3/4885
US-20190337966-A1 NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR CYP24A1, CYP26B1, CYP21A2 CYP1A2 115/4885CYP2A6 96/4885TP53 3878/4885
US-20190214583-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, AOC3 CYP1A2 224/4885CYP2A6 1610/4885TP53 4372/4885
US-20230399302-A1 PROCESS FOR THE PREPARATION OF HETEROARYL-SUBSTITUTED SULFUR(VI) COMPOUNDS TST, TYR, STS CYP1A2 162/4885CYP2A6 49/4885TP53 861/4885
US-20230339952-A1 MACROCYCLIC HETEROCYCLES AND USES THEREOF HRAS, KRAS, TP53 CYP1A2 4819/4885CYP2A6 4850/4885TP53 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.